{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T14:54:45Z","timestamp":1714575285445},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/bf03345607","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T11:17:37Z","timestamp":1395487057000},"page":"592-596","source":"Crossref","is-referenced-by-count":5,"title":["Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children?"],"prefix":"10.1007","volume":"31","author":[{"given":"M. I.","family":"Spagnuolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. F.","family":"Vallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Officioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Volpicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"BF03345607_CR1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999, 353: 2093\u20139.","journal-title":"Lancet"},{"key":"BF03345607_CR2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/74.5.679","volume":"74","author":"AY McDermott","year":"2001","unstructured":"McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayas J, Gorbach S. Effect of highly active antiretroviral therapy on fat, lean, bone mass in HIV-seropositive men and women. Am J Clin Nutr 2001, 74: 679\u201386.","journal-title":"Am J Clin Nutr"},{"key":"BF03345607_CR3","first-page":"463","volume":"22","author":"JL Bochkorst","year":"2003","unstructured":"Bochkorst JL, Ksseriy I, Toye M, et al. Evidence of human immunodeficiency virus associated lipodystrophy syndrome in children with protease inhibitors Pediatr Infect Dis J 2003, 22: 463\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"BF03345607_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1071\/SH04058","volume":"2","author":"D Nolan","year":"2005","unstructured":"Nolan D, Mallal S. Antiretroviral-therapy-associated lipoatrophy: current status and future directions Sex Health 2005, 2: 153\u201363.","journal-title":"Sex Health"},{"key":"BF03345607_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350300800102","volume":"8","author":"L Kosmiski","year":"2003","unstructured":"Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R. Adipocyte-derived hormone levels in HIV lipodystrophy Antivir Ther 2003, 8: 9\u201315.","journal-title":"Antivir Ther"},{"key":"BF03345607_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","volume":"11","author":"RS Ahima","year":"2000","unstructured":"Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000, 11: 327\u201332.","journal-title":"Trends Endocrinol Metab"},{"key":"BF03345607_CR7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jc.2003-031315","volume":"89","author":"M Bajaj","year":"2004","unstructured":"Bajaj M, Suraamornkul S, Piper P, et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004, 89: 200\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345607_CR8","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","volume":"15","author":"MA Noor","year":"2001","unstructured":"Noor MA, Lo JC, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 2001, 15: F11\u20138.","journal-title":"AIDS"},{"key":"BF03345607_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00126334-200201010-00004","volume":"29","author":"V Estrada","year":"2002","unstructured":"Estrada V, Serrano-Rios M, Martinez Larrad MT, et al. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002, 29: 32\u201340.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF03345607_CR10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.280.21.1843","volume":"280","author":"KM Rexrode","year":"1998","unstructured":"Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280: 1843\u20138.","journal-title":"JAMA"},{"key":"BF03345607_CR11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","volume":"32","author":"A Vigano","year":"2003","unstructured":"Vigano A, Mora S, Testolin C, et al. Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr 2003, 32: 482\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF03345607_CR12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4158\/EP.7.6.430","volume":"7","author":"AL Graber","year":"2001","unstructured":"Graber AL. Syndrome of lipodystrophy, hyperlipidemia, insulin resistance, and diabetes in treated patients with human immunodeficiency virus infection. Endocr Pract 2001, 7: 430\u20137.","journal-title":"Endocr Pract"},{"key":"BF03345607_CR13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1381\/096089202321019620","volume":"12","author":"AE Pontiroli","year":"2002","unstructured":"Pontiroli AE, Pizzocri P, Giacomelli M, et al. Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements. Obes Surg 2002, 12: 648\u201351.","journal-title":"Obes Surg"},{"key":"BF03345607_CR14","first-page":"315","volume":"5","author":"F Armellini","year":"1997","unstructured":"Armellini F, Zamboni M, Harris T, Micciolo R, Bosello O. Sagittal diameter minus subcutaneous thickness. An easy-to-obtain parameter that improves visceral fat prediction. Obes Res 1997, 5: 315\u201320.","journal-title":"An easy-to-obtain parameter that improves visceral fat prediction. Obes Res"},{"key":"BF03345607_CR15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.ijo.0800643","volume":"22","author":"M Zamboni","year":"1998","unstructured":"Zamboni M, Turcato E, Armellini F, et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes Relat Metab Disord 1998, 22: 655\u201360.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF03345607_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","volume":"25","author":"DC Mynarcik","year":"2000","unstructured":"Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC. Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr 2000, 25: 312\u201321.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF03345607_CR17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","volume":"255","author":"CM Steppan","year":"2004","unstructured":"Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004, 255: 439\u201347.","journal-title":"J Intern Med"},{"key":"BF03345607_CR18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","volume":"140","author":"C Hadigan","year":"2004","unstructured":"Hadigan C, Yawetz S, Thomas A, Havers F, Sax PE, Grinspoon S. Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized controlled trial. Ann Intern Med 2004, 140: 786\u201394.","journal-title":"Ann Intern Med"},{"key":"BF03345607_CR19","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1210\/jc.2005-0742","volume":"90","author":"D Barb","year":"2005","unstructured":"Barb D, Wadhwa SG, Kratzsch J, et al. Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome. J Clin Endocrinol Metab 2005, 90: 5324\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345607_CR20","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1210\/jc.2005-0287","volume":"90","author":"D Kamin","year":"2005","unstructured":"Kamin D, Hadigan C, Lehrke M, Mazza S, Lazar MA, Grinspoon S. Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab 2005, 90: 3423\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345607_CR21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","volume":"89","author":"BS Youn","year":"2004","unstructured":"Youn BS, Yu KY, Park HJ, et al. Plasma resistin concentrations measured by ELISA using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004, 89: 150\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345607_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2003.09.009","volume":"339","author":"A Fujinami","year":"2004","unstructured":"Fujinami A, Obayashi H, Ohta K, et al. Enzymelinked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004, 339: 57\u201363.","journal-title":"Clin Chim Acta"},{"key":"BF03345607_CR23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diabetes.53.5.1279","volume":"53","author":"B Courten Volarova de","year":"2004","unstructured":"Volarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004, 53: 1279\u201384.","journal-title":"Diabetes"},{"key":"BF03345607_CR24","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","volume":"88","author":"JH Lee","year":"2003","unstructured":"Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003, 88: 4848\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345607_CR25","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1152\/ajpendo.00457.2002","volume":"285","author":"B Moon","year":"2003","unstructured":"Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 2003, 285: E106\u201315.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BF03345607_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI16521","volume":"111","author":"MW Rajala","year":"2003","unstructured":"Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-\u03b2 selectively impair insulin action on glucose production. J Clin Invest 2003, 111: 225\u201330.","journal-title":"J Clin Invest"},{"key":"BF03345607_CR27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-291X(02)02864-4","volume":"300","author":"JN Fain","year":"2003","unstructured":"Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003, 300: 674\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03345607_CR28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","volume":"50","author":"DB Savage","year":"2001","unstructured":"Savage DB, Sewter CP, Klenk ES, et al. Resistin\/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor \u2014 action in humans. Diabetes 2001, 50: 2199\u2013202.","journal-title":"Diabetes"},{"key":"BF03345607_CR29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","volume":"309","author":"S Kaser","year":"2003","unstructured":"Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger \u2014 RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003, 309: 286\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03345607_CR30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","volume":"300","author":"L Patel","year":"2003","unstructured":"Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR activators. Biochem Biophys Res Commun 2003, 300: 472\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03345607_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.ejcn.1601314","volume":"56","author":"E Cacciari","year":"2002","unstructured":"Cacciari E, Milani S, Balsamo A, Dammacco F, De Luca F, Chiarelli F. Italian cross-sectional growth charts for height, weight and BMI (6\u201320 y). Eur J Clin Nutr 2002, 56: 171\u201380.","journal-title":"Eur J Clin Nutr"},{"key":"BF03345607_CR32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","volume":"18","author":"European Paediatric Lipopdystrophy Group.","year":"2004","unstructured":"European Paediatric Lipopdystrophy Group. Anteretroviral therapy, fat redistribution and hyperlipidemia in HIV-infected children in Europe. AIDS 2004, 18: 1443\u201351.","journal-title":"AIDS"},{"key":"BF03345607_CR33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.ijo.0801968","volume":"26","author":"MB Snijder","year":"2002","unstructured":"Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord 2002, 26: 984\u201393.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF03345607_CR34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1006\/pmed.1998.0376","volume":"27","author":"TB Hickman","year":"1998","unstructured":"Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4\u201319 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998, 27: 879\u201390.","journal-title":"Prev Med"},{"key":"BF03345607_CR35","first-page":"124","volume":"30","author":"Z Laron","year":"1977","unstructured":"Laron Z, Huerter P, Weber B. Standardization of oral glucose tolerance test. Acta Paediatr Belg 1977, 30: 124\u20135.","journal-title":"Acta Paediatr Belg"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345607\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:08:52Z","timestamp":1689077332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BF03345607"],"URL":"https:\/\/doi.org\/10.1007\/bf03345607","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}